Matthew Wright

2.5k citations

85 papers · 1.8k indexed · h-index 25

Impact in

Pharmacology top 1%
- Pharmacogenetics and Drug Metabolism
Hematology top 5%
- Blood Coagulation and Thrombosis Mechanisms

Papers in ⓘ

Pharmacology 19
- Pharmacogenetics and Drug Metabolism 19
- Antibiotics Pharmacokinetics and Efficacy 6
Virology 7
- HIV Research and Treatment 7

Co-authors: Fakhreddin Jamali (7 shared papers)Cornelis E. C. A. Hop (14 shared papers)Pancras C. Wong (11 shared papers)Robert M. Knabb (11 shared papers)Ruth R. Wexler (11 shared papers)Xingrong Liu (1 shared paper)Richard Alexander (7 shared papers)Donald Pinto (5 shared papers)
Journals: Bioorganic & Medicinal Chemistry Letters (11 papers)Journal of Medicinal Chemistry (10 papers)Drug Metabolism and Disposition (7 papers)Journal of Pharmacology and Experimental Therapeutics (7 papers)Journal of Pharmaceutical Sciences (3 papers)
Partner nations: United States Canada France

In The Last Decade

Matthew Wright

82 papers receiving 1.7k citations

Peers

Countries citing papers authored by Matthew Wright

Since Specialization

Citations

This map shows the geographic impact of Matthew Wright's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Matthew Wright with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Matthew Wright more than expected).

Fields of papers citing papers by Matthew Wright

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Matthew Wright. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Matthew Wright. The network helps show where Matthew Wright may publish in the future.

Co-authors

The 25 scholars most cited alongside Matthew Wright, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Matthew Wright Line = papers co-authored together Matthew Wright links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Showing the 20 most-cited of 85 papers — load more, or switch the sort, to bring in the rest.

#	Work
1	Discovery of 1-[3-(Aminomethyl)phenyl]-N-[3-fluoro-2‘-(methylsulfonyl)- [1,1‘-biphenyl]-4-yl]-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide (DPC423), a Highly Potent, Selective, and Orally Bioavailable Inhibitor of Blood Coagulation Factor Xa Journal of Medicinal Chemistry ·Donald Pinto, Michael J. Orwat, Shuaige Wang, John M. Fevig, Mimi L. Quan, Eugene Amparo, Joseph Cacciola, Karen A. Rossi, Richard Alexander, Angela Smallwood, Joseph M. Luettgen, Li Liang, Bruce J. Aungst, Matthew Wright, Robert M. Knabb, Pancras C. Wong, Ruth R. Wexler, Patrick Y. S. Lam	2001	139
2	Rational Use of Plasma Protein and Tissue Binding Data in Drug Design Journal of Medicinal Chemistry ·Xingrong Liu, Matthew Wright, Cornelis E. C. A. Hop	2014	126
3	Special Section on Pharmacokinetic and Drug Metabolism Properties of Novel Therapeutic Modalities–Minireview Drug Metabolism and Disposition ·Donglu Zhang, Cornelis E. C. A. Hop, Gabriela I. Patilea‐Vrana, Gautham Gampa, Herana Kamal Seneviratne, Jashvant D. Unadkat, Jane R. Kenny, Karthik Nagapudi, Li Di, Lian Zhou, Mark Zak, Matthew Wright, Namandjé N. Bumpus, Richard Zang, Xingrong Liu, Yurong Lai, S. Cyrus Khojasteh	2019	81
4	Structure-Based Design of Novel Guanidine/Benzamidine Mimics: Potent and Orally Bioavailable Factor Xa Inhibitors as Novel Anticoagulants Journal of Medicinal Chemistry ·Patrick Y. S. Lam, Charles G. Clark, Renhua Li, Donald Pinto, Michael J. Orwat, Robert A. Galemmo, John M. Fevig, Christopher A. Teleha, Richard Alexander, Angela Smallwood, Karen A. Rossi, Matthew Wright, Stephen A. Bai, Kan He, Joseph M. Luettgen, Pancras C. Wong, Robert M. Knabb, Ruth R. Wexler	2003	70
5	Design and Synthesis of Isoxazoline Derivatives as Factor Xa Inhibitors. 2 Journal of Medicinal Chemistry ·Mimi L. Quan, Christopher D. Ellis, Ann Y. Liauw, Richard Alexander, Robert M. Knabb, Gilbert N. Lam, Matthew Wright, Pancras C. Wong, Ruth R. Wexler	1999	67
6	Hepatic metabolism and biliary excretion of Taxol in rats and humans. PubMed ·Bernard Monsarrat, Paul Alvinerie, Matthew Wright, Joëlle Dubois, Françoise Guéritte-Voegelein, Daniel Guénard, Ross C. Donehower, E.K. Rowinsky	1993	60
7	Isoxazolines and isoxazoles as factor Xa inhibitors Bioorganic & Medicinal Chemistry Letters ·James R. Pruitt, Donald Pinto, Melissa Estrella, Lori L. Bostrom, Robert M. Knabb, Pancras C. Wong, Matthew Wright, Ruth R. Wexler	2000	59
8	Discovery of 1-(2-Aminomethylphenyl)-3-trifluoromethyl-N- [3-fluoro-2‘-(aminosulfonyl)[1,1‘-biphenyl)]-4-yl]-1H-pyrazole-5-carboxyamide (DPC602), a Potent, Selective, and Orally Bioavailable Factor Xa Inhibitor Journal of Medicinal Chemistry ·James R. Pruitt, Donald Pinto, Robert A. Galemmo, Richard Alexander, Karen A. Rossi, Brian L. Wells, Spencer Drummond, Lori L. Bostrom, Debra Burdick, R. Brückner, Haiying Chen, Angela Smallwood, Pancras C. Wong, Matthew Wright, Steven Bai, Joseph M. Luettgen, Robert M. Knabb, Patrick Y. S. Lam, Ruth R. Wexler	2003	58
9	Preclinical Evaluation of GS-9160, a Novel Inhibitor of Human Immunodeficiency Virus Type 1 Integrase Antimicrobial Agents and Chemotherapy ·G.S. Jones, Fang Yu, Ameneh Zeynalzadegan, Joseph Hesselgesser, Xiao‐Wu Chen, James Chen, Haolun Jin, Choung U. Kim, Matthew Wright, Romas Geleziunas, Manuel Tsiang	2008	44
10	Improved high-performance liquid chromatographic assay method for the enantiomers of ibuprofen Journal of Chromatography B Biomedical Sciences and Applications ·Matthew Wright, Saeed Sattari, Dion R. Brocks, Fakhreddin Jamali	1992	43
11	Nonsymmetric P2/P2‘ Cyclic Urea HIV Protease Inhibitors. Structure−Activity Relationship, Bioavailability, and Resistance Profile of Monoindazole-Substituted P2 Analogues Journal of Medicinal Chemistry ·George V. De Lucca, Ui T. Kim, Jing Liang, Beverly C. Cordova, Ronald M. Klabe, Sena Garber, Lee T. Bacheler, Gilbert N. Lam, Matthew Wright, Kelly Logue, Susan Erickson‐Viitanen, Soo S. Ko, George L. Trainor	1998	43
12	Optimizing the use of cyclosporine in renal transplantation Clinical Biochemistry ·Ingrid Sketris, Randall W. Yatscoff, Paul Keown, Daniel M. Canafax, M. Roy First, D W Holt, Timothy Schroeder, Matthew Wright	1995	42
13	Nonpeptide Factor Xa Inhibitors III: Effects of DPC423, an Orally-Active Pyrazole Antithrombotic Agent, on Arterial Thrombosis in Rabbits Journal of Pharmacology and Experimental Therapeutics ·Pancras C. Wong, Earl J. Crain, Carol A. Watson, Alverna M. Zaspel, Matthew Wright, Patrick Y. S. Lam, Donald Pinto, Ruth R. Wexler, Robert M. Knabb	2002	42
14	Drug disposition and effects in the fetus. PubMed ·Dan Rurak, Matthew Wright, James E. Axelson	1991	42
15	Antiinflammatory Drug-Induced Small Intestinal Permeability: The Rat Is a Suitable Model Pharmaceutical Research ·Neal M. Davies, Matthew Wright, Fakhreddin Jamali	1994	40
16	Limited extent of stereochemical conversion of chiral non-steroidal anti-inflammatory drugs induced by derivatization methods employing ethyl chloroformate Journal of Chromatography B Biomedical Sciences and Applications ·Matthew Wright, Fakhreddin Jamali	1993	35
17	Effect of the Enantiomers of Flurbiprofen, Ibuprofen, and Ketoprofen on Intestinal Permeability Journal of Pharmaceutical Sciences ·Neal M. Davies, Matthew Wright, Anthony S. Russell, Fakhreddin Jamali	1996	35
18	Design and selection of DMP 850 and DMP 851: the next generation of cyclic urea HIV protease inhibitors Chemistry & Biology ·James D. Rodgers, Patrick Y. S. Lam, Barry L. Johnson, Haisheng Wang, Soo S. Ko, Steven P. Seitz, George L. Trainor, Paul Anderson, Ronald M. Klabe, Lee T. Bacheler, Beverly C. Cordova, Sena Garber, Carol Reid, Matthew Wright, Chang-Hwan Chang, Susan Erickson‐Viitanen	1998	32
19	Design, Synthesis, and Biological Evaluation of Potent and Selective Amidino Bicyclic Factor Xa Inhibitors Journal of Medicinal Chemistry ·Qi Han, Celia Dominguez, Pieter F. W. Stouten, Jeongsook M. Park, Daniel E. Duffy, Robert A. Galemmo, Karen A. Rossi, Richard Alexander, Angela Smallwood, Pancras C. Wong, Matthew Wright, Joseph M. Luettgen, Robert M. Knabb, Ruth R. Wexler	2000	30
20	Entering the era of computationally driven drug development Drug Metabolism Reviews ·Neha Maharao, Victor Antontsev, Matthew Wright, Jyotika Varshney	2020	29

About Matthew Wright

Matthew Wright is a scholar working on Pharmacology, Virology, Hematology, Oncology and Infectious Diseases, having authored 85 papers that have together received 1.8k indexed citations. Recurring topics across this work include Drug Transport and Resistance Mechanisms (21 papers), Pharmacogenetics and Drug Metabolism (19 papers), Blood Coagulation and Thrombosis Mechanisms (10 papers), HIV/AIDS drug development and treatment (10 papers), HIV Research and Treatment (7 papers), Computational Drug Discovery Methods (7 papers), Antibiotics Pharmacokinetics and Efficacy (6 papers) and Coagulation, Bradykinin, Polyphosphates, and Angioedema (5 papers). The work is most often cited by research in Pharmacology (284 citations), Hematology (249 citations), Virology (104 citations), Internal Medicine (61 citations) and Pharmaceutical Science (98 citations). Matthew Wright has collaborated with scholars based in United States, Canada and France. Frequent co-authors include Fakhreddin Jamali, Cornelis E. C. A. Hop, Pancras C. Wong, Robert M. Knabb, Ruth R. Wexler, Xingrong Liu, Richard Alexander, Donald Pinto, Patrick Y. S. Lam and Mimi L. Quan. Their work appears in journals such as Bioorganic & Medicinal Chemistry Letters, Journal of Medicinal Chemistry, Drug Metabolism and Disposition, Journal of Pharmacology and Experimental Therapeutics and Journal of Pharmaceutical Sciences.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact